Evaluating the Role of Vascular Surgeons in Surgery for Retroperitoneal Tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with retroperitoneal tumors that involve abdominal and pelvic vascular structures, assessing the outcomes of surgical procedures with vascular surgical assistance. The study aims to gather data on the effectiveness of different surgical approaches and the impact of vascular surgeon involvement on patient outcomes. By analyzing a larger sample size, the research seeks to provide insights into surgical resection techniques and revascularization methods. The ultimate goal is to improve surgical strategies and reduce complications associated with these complex surgeries.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient diagnosed with a retroperitoneal mass involving the abdominal and/or pelvic vascular structures and requiring surgical removal
* Planned surgical treatment with intra-operative assistance from the vascular surgeon
* Obtaining informed consent
* Age 18 years

Exclusion Criteria:

\-

Where it's running

• IRCCS AOU di Bologna Policlinico di Sant'Orsola
  Bologna, Italia, Italy Recruiting

Study contacts

• Principal investigator: Mauro Gargiulo, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Mauro MG Gargiulo, MD
• Email: mauro.gargiulo2@unibo.it
• Phone: 0512143288

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Retroperitoneal Tumor Registry

  This observational registry collects real-world data from people with retroperitoneal tumors to help understand features, treatments, and long-term outcomes.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT07915895

• Personalised neoadjuvant therapy planning for adults with high‑risk soft tissue sarcoma

  This project tests whether analyzing tumor tissue and clinical data can help guide neoadjuvant chemotherapy decisions for adults with high‑risk soft tissue sarcomas.

  Recruiting Royal Marsden NHS Foundation Trust · London · NCT07432932

• Assessing colorectal resections in patients with retroperitoneal sarcoma

  This study is trying to see how different surgical techniques for removing retroperitoneal sarcomas affect patients' recovery and quality of life.

  Recruiting at 16 sites Heidelberg University · Mannheim, Baden-Wurttemberg and 15 other locations · NCT06943612

• Short course radiation treatment for retroperitoneal sarcoma before surgery

  This study is testing a shorter radiation treatment for patients with retroperitoneal sarcoma to see if it can be safely used before surgery.

  Recruiting Phase 1 Brigham and Women's Hospital · Boston, Massachusetts · NCT06812052

• Electrochemotherapy for unresectable visceral tumors including liver metastases

  This will try electrochemotherapy with bleomycin in adults who have unresectable primary or metastatic visceral tumors, such as liver metastases.

  Recruiting Istituto Oncologico Veneto IRCCS · Padova · NCT06753136

• Proton therapy combined with standard radiation for treating retroperitoneal sarcoma

  This study is testing a new type of radiation therapy combined with standard treatment to see if it helps people with newly diagnosed retroperitoneal sarcoma before they have surgery.

  Recruiting Phase 1/2 Northwestern University · Chicago, Illinois · NCT06327477

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.